Recursion Pharmaceuticals, Inc. Class A RXRX 深 沪
等待开盘 04-02 09:30:00 美东时间
3.06
-0.010
-0.33%
华盛通- 最 高3.21
- 今 开3.13
- 成交量 1085.64万股
- 最 低 3.04
- 昨 收 3.07
- 总市值 16.14亿
- 52周最高 7.18
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.80
- 委 比 -60.74%
- 总股本 5.27亿
- 历史最高 42.81
- 量 比 0.74
- 振 幅 5.54%
- 历史最低 2.80
- 每 手 1
- 风险率 0.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Recursion names Vicki Goodman as CMO
Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in...
03-25 20:44
Recursion names Vicki Goodman chief medical officer effective April 6, 2026; David Mauro exits after about three years
Recursion names Vicki Goodman chief medical officer effective April 6, 2026; David Mauro exits after about three years Recursion named Vicki Goodman as Chief Medical Officer effective April 6, 2026, as David Mauro transitions out of the role after about three years. Most recently, Goodman served as
03-25 19:59
美股夜盘 | Hims & Hers Health, Inc. Class A涨19.95%，金山云涨13.59%
Hims & Hers Health, Inc. Class A涨19.95%；金山云涨13.59%；PMGC Holdings Inc.涨4.91%
03-09 15:01
美股夜盘 | Hims & Hers Health, Inc. Class A涨19.95%，金山云涨8.42%
Hims & Hers Health, Inc. Class A涨19.95%；金山云涨8.42%；RED CAT HOLDINGS涨6.71%
03-09 13:02
美股夜盘 | Hims & Hers Health, Inc. Class A涨19.95%，金山云涨5.92%
Hims & Hers Health, Inc. Class A涨19.95%；金山云涨5.92%；RED CAT HOLDINGS涨5.73%
03-09 10:01
美股夜盘 | 尚乘数科涨44.57%，RED CAT HOLDINGS涨9.01%
房多多涨-10.26%；Recursion Pharmaceuticals, Inc. Class A涨-5.99%；SoundHound AI, Inc Class A涨-5.81%
03-02 09:10
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
Needham Reiterates Buy on Recursion Pharmaceuticals, Maintains $8 Price Target
Needham analyst Gil Blum reiterates Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and maintains $8 price target.
02-26 19:24
Recursion jumps after solid Q4 beat
Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone p...
02-26 00:42
